(Q42171606)
Statements
1 reference
Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP). (English)
1 reference
George G Zhanel
1 reference
Ayman M Noreddin
1 reference
Theodore K Marras
1 reference
Kevin Sanders
1 reference
Charles K N Chan
1 reference
Daryl J Hoban
1 reference
1 November 2004
1 reference
1 reference
24
1 reference
5
1 reference
479-484
1 reference
Identifiers
1 reference
1 reference